Healthcare · Drug Manufacturers Specialty Generic · TSX
Knight Therapeutics Inc. (GUD.TO) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.01B, a trailing price-to-earnings ratio of 51.5 and a free-cash-flow yield of 3.4%. Over the most recent reported fiscal year, revenue grew 21.2% and free cash flow per share grew 647.2%.